ID   vFOP4-3
AC   CVCL_W554
SY   CiRA00042; HPS0377
DR   RCB; HPS0377
DR   SKIP; SKIP000338
DR   SKIP; SKIP003026
DR   Wikidata; Q54993080
RX   PubMed=24321451;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W553 ! vFOP4-1
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
RX   PubMed=24321451; DOI=10.1186/1750-1172-8-190;
RA   Matsumoto Y., Hayashi Y., Schlieve C.R., Ikeya M., Kim H.,
RA   Nguyen T.D., Sami S., Baba S., Barruet E., Nasu A., Asaka I.,
RA   Otsuka T., Yamanaka S., Conklin B.R., Toguchida J., Hsiao E.C.;
RT   "Induced pluripotent stem cells from patients with human
RT   fibrodysplasia ossificans progressiva show increased mineralization
RT   and cartilage formation.";
RL   Orphanet J. Rare Dis. 8:190.1-190.14(2013).
//